• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    Advaxis, Inc. (ADXS)

    -NasdaqCM
    8.23 0.50(6.47%) Jan 26, 4:00PM EST
    Add to Portfolio
    Prev Close:7.73
    Open:7.77
    Bid:8.16 x 200
    Ask:8.45 x 1000
    1y Target Est:11.67
    Beta:1.29
    Next Earnings Date:N/A
    Day's Range:7.49 - 8.33
    52wk Range:2.46 - 13.74
    Volume:1,131,814
    Avg Vol (3m):934,303
    Market Cap:194.59M
    P/E (ttm):N/A
    EPS (ttm):-0.97
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADXS

    Comparison

    Symbol% ChgMkt Cap
    ADXSUp 6.47%194.59M
    BVTIN/A
    DNDNN/A
    VICL97.56M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):182.77
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Oct-15) :-1.11
    Quarterly EPS Est (Jan-15) :-0.29
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback